39 min
Ep 12: Chris Gibson on Building a Platform Biotech and The Future of R&D Vital Signs with Jacob Effron and Nikhil Krishnan
-
- Investing
Jacob sits down with Chris Gibson, the co-founder and CEO of Recursion, to discuss how Recursion predicted drugs that would be effective for COVID, his take on different techbio business models, what pharma R&D will look like in 25 years and more.
Jacob sits down with Chris Gibson, the co-founder and CEO of Recursion, to discuss how Recursion predicted drugs that would be effective for COVID, his take on different techbio business models, what pharma R&D will look like in 25 years and more.
39 min